Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | PRKDC | P78527 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MMP12 | P39900 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24130691 | 0.99 | AHR (0.39) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL17944446 | 0.95 | MEN1 (0.38) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL17945385 | 0.95 | MAOA (0.42) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL22706482 | 0.93 | ALOX5 (0.39) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL17944444 | 0.93 | AHR (0.36) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL17944448 | 0.93 | AHR (0.36) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL17932190 | 0.93 | HCRTR1 (0.34) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL17944170 | 0.93 | ALOX5 (0.40) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL20026475 | 0.92 | AHR (0.41) | AHRMEN1KMT2AMAPTKDM4E | |
| SCHEMBL22155606 | 0.92 | MAOA (0.37) | AHRMEN1KMT2AMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120309974-A1 | Bianthracene compounds substituted by aromatic ring and their uses for luminescence materials | BEIJING AGLAIA TECHNOLOGY DEVELOPMENT CO., LTD (CN) | 2012-12-06 | — | — | US | disclosed |
| US-20120309974-A1 | Bianthracene compounds substituted by aromatic ring and their uses for luminescence materials | BEIJING AGLAIA TECHNOLOGY DEVELOPMENT CO., LTD (CN) | 2012-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309974-A1 | Bianthracene compounds substituted by aromatic ring and their uses for luminescence materials | TYR, GALNT1, GALNT2 | AHR 18/4885MEN1 2686/4885KMT2A 2295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.